Opioid PMR Study
Research payments
$8,384
Through program year 2021, $8,384 in research payments was reported against Opioid PMR Study, across 23 payments, paid by Hikma Pharmaceuticals USA.
- Paid by
- Hikma Pharmaceuticals USA
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $1,500 | 3 |
| 2020 | Research | $6,884 | 20 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Martin Angst Stanford, CA Named on 2 payments
- Charles Argoff Albany, NY Named on 2 payments
- Mark Woyshville Middleburg Heights, OH Named on 1 payment
- John McGettigan Tucson, AZ Named on 1 payment
- John Markman Rochester, NY Named on 1 payment
- Anthony Rogers Lake Worth, FL Named on 1 payment
- Derek Muse Salt Lake City, UT Named on 1 payment
- Jose Chung Montgomery, AL Named on 1 payment
- Michael Hassman Berlin, NJ Named on 1 payment
- Daniel Gruener Philadelphia, PA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.